133 related articles for article (PubMed ID: 7634615)
1. Facilitation and suppression of bone metastasis.
Mundy GR; Yoneda T
Clin Orthop Relat Res; 1995 Mar; (312):34-44. PubMed ID: 7634615
[TBL] [Abstract][Full Text] [Related]
2. Malignancy and the skeleton.
Mundy GR
Horm Metab Res; 1997 Mar; 29(3):120-7. PubMed ID: 9137982
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of bone cancer pain.
Sabino MA; Mantyh PW
J Support Oncol; 2005; 3(1):15-24. PubMed ID: 15724942
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and treatment for bone metastases.
Clines GA; Guise TA
Clin Adv Hematol Oncol; 2004 May; 2(5):295-302. PubMed ID: 16163196
[TBL] [Abstract][Full Text] [Related]
5. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of skeletal metastases.
Choong PF
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S19-31. PubMed ID: 14600589
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
8. [The application advances of bisphosphonates in bone metastasis].
Liang P
Zhongguo Gu Shang; 2008 Jun; 21(6):480-2. PubMed ID: 19108448
[TBL] [Abstract][Full Text] [Related]
9. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
10. Biology of bone cancer pain.
Goblirsch MJ; Zwolak PP; Clohisy DR
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6231s-6235s. PubMed ID: 17062706
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer bone metastasis and current small therapeutics.
Cicek M; Oursler MJ
Cancer Metastasis Rev; 2006 Dec; 25(4):635-44. PubMed ID: 17160709
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
[TBL] [Abstract][Full Text] [Related]
13. Tumor metastasis to bone.
Virk MS; Lieberman JR
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S5. PubMed ID: 17634144
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
15. Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis.
Niikura K
Cancer Chemother Pharmacol; 2007 Sep; 60(4):555-62. PubMed ID: 17187252
[TBL] [Abstract][Full Text] [Related]
16. A mathematical model for describing the metastasis of cancer in bone tissue.
Garzón-Alvarado DA
Comput Methods Biomech Biomed Engin; 2012; 15(4):333-46. PubMed ID: 21264782
[TBL] [Abstract][Full Text] [Related]
17. How can we improve the treatment of bone metastases further?
Coleman RE
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
[TBL] [Abstract][Full Text] [Related]
18. Targeting of therapeutic agents to bone to treat metastatic cancer.
Bagi CM
Adv Drug Deliv Rev; 2005 May; 57(7):995-1010. PubMed ID: 15876400
[TBL] [Abstract][Full Text] [Related]
19. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
[TBL] [Abstract][Full Text] [Related]
20. Decorin suppresses bone metastasis in a breast cancer cell line.
Araki K; Wakabayashi H; Shintani K; Morikawa J; Matsumine A; Kusuzaki K; Sudo A; Uchida A
Oncology; 2009; 77(2):92-9. PubMed ID: 19590249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
